These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9505183)

  • 21. Utility of 67Ga scintigraphy in disseminated infection after BCG instillation for treatment of bladder carcinoma.
    Dominguez ML; Ortiz A; Rayo JI; Serrano J; Infante JR; Garcia L; Duran C
    Clin Nucl Med; 2013 Aug; 38(8):658-60. PubMed ID: 23751826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Four cases of disseminated Mycobacterium bovis infection following intravesical BCG instillation for treatment of bladder carcinoma.
    Nadasy KA; Patel RS; Emmett M; Murillo RA; Tribble MA; Black RD; Sutker WL
    South Med J; 2008 Jan; 101(1):91-5. PubMed ID: 18176300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prosthetic joint infection due to Mycobacterium bovis 5-years after BCG-instillations.
    Goedertier W; Sioen W
    Acta Orthop Belg; 2020 Jun; 86(2):239-242. PubMed ID: 33418613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal Tuberculosis Following Intravesical Bacillus Calmette-Guérin (BCG) Immunotherapy for the Treatment of Bladder Cancer.
    Bajramovic S; Alic J; Skopljak E; Chikha A; Vesnic S; Smajilbegovic V; Aganovic D
    Med Arch; 2020 Apr; 74(2):146-150. PubMed ID: 32577059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histopathology of Disseminated Mycobacterium bovis Infection Complicating Intravesical BCG Immunotherapy for Urothelial Carcinoma.
    Larsen BT; Smith ML; Grys TE; Vikram HR; Colby TV
    Int J Surg Pathol; 2015 May; 23(3):189-95. PubMed ID: 25614462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ruptured mycotic abdominal aortic aneurysm secondary to Mycobacterium bovis after intravesical treatment with bacillus Calmette-Guérin.
    Harding GE; Lawlor DK
    J Vasc Surg; 2007 Jul; 46(1):131-4. PubMed ID: 17606130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mycobacterium bovis vertebral osteomyelitis as a complication of intravesical BCG use.
    Abu-Nader R; Terrell CL
    Mayo Clin Proc; 2002 Apr; 77(4):393-7. PubMed ID: 11936937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A thoracic tuberculous spondylodisctis after intravesical BCG immunotherapy of bladder cancer - Case report and literature review.
    Dąbrowska M; Drabarek T; Muraszko-Klaudel A; Sławek J
    Neurol Neurochir Pol; 2015; 49(6):460-6. PubMed ID: 26652884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Added value of use of a purified protein derivative-based enzyme-linked immunosorbent spot assay for patients with Mycobacterium bovis BCG infection after intravesical BCG instillations.
    Heemstra KA; Bossink AW; Spermon R; Bouwman JJ; van der Kieft R; Thijsen SF
    Clin Vaccine Immunol; 2012 Jun; 19(6):974-7. PubMed ID: 22461529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Back pain following instillations of BCG for superficial bladder cancer is not a reactive complication: review of 30 Mycobacterium bovis BCG vertebral osteomyelitis cases.
    Cadiou S; Al Tabaa O; Nguyen CD; Faccin M; Guillin R; Revest M; Guggenbuhl P; Houvenagel E; Pertuiset E; Coiffier G
    Clin Rheumatol; 2019 Jun; 38(6):1773-1783. PubMed ID: 30868320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic bacillus Calmette-Guerin infection in patients treated by intravesical BCG therapy for superficial bladder cancer.
    Steg A; Leleu C; Debré B; Boccon-Gibod L; Sicard D
    Prog Clin Biol Res; 1989; 310():325-34. PubMed ID: 2672020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mycobacterial infection after intravesical bacillus Calmette-Guërin treatment for bladder cancer: a case report.
    Park CH; Jang MA; Ahn YH; Hwang YY; Ki CS; Lee NY
    Korean J Lab Med; 2011 Jul; 31(3):197-200. PubMed ID: 21779195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Two cases of successful treatments with steroid for local and systemic hypersensitivity reaction following intravesical instillation of Bacillus Calmette-Guerin].
    Shimasaki N; Yamasaki I; Kamada M; Syuin T
    Hinyokika Kiyo; 2001 Apr; 47(4):281-4. PubMed ID: 11411106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Miliary pulmonary infection after BCG intravesical instillation: a rare, misdiagnosed and mistreated complication.
    Calleris G; Marra G; Corcione S; Oderda M; Cardellino C; Audagnotto S; Frea B; De Rosa FG; Gontero P
    Infez Med; 2017 Dec; 25(4):366-370. PubMed ID: 29286018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravesical versus intravesical plus intradermal bacillus Calmette-Guerin: a prospective randomized study in patients with recurrent superficial bladder tumors.
    Lüftenegger W; Ackermann DK; Futterlieb A; Kraft R; Minder CE; Nadelhaft P; Studer UE
    J Urol; 1996 Feb; 155(2):483-7. PubMed ID: 8558641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Difficulties in Diagnosing and Treating Disseminated Bacillus Calmette-Guérin (BCG) Infection After Intravesical BCG Therapy in a Patient with Liver Cirrhosis: A Case Report.
    Vallilas C; Zachou M; Dolkiras P; Sakellariou S; Constantinou CA; Flevari P; Anastasopoulou A; Androutsakos T
    Am J Case Rep; 2021 Oct; 22():e933006. PubMed ID: 34654796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Henoch-Schönlein purpura after intravesical administration of bacillus Calmette-Guérin.
    Nan DN; Fernández-Ayala M; García-Ibarbia C; Gutiérrez-Santiago M; Hernández JL
    Scand J Infect Dis; 2005; 37(8):613-615. PubMed ID: 16138436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Acute respiratory failure and septic shock induced by Mycobacterium bovis. A rare side effect of intravesical BCG therapy].
    Rival G; Garot D; Mercier E; Narciso B; Legras A; Perrotin D; Dequin PF
    Presse Med; 2006 Jun; 35(6 Pt 1):980-2. PubMed ID: 16783258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bilateral Granulomatous Renal Masses after Intravesical BCG Therapy for Non-muscle-invasive Bladder Cancer and Carcinoma in Situ of the Upper Urinary Tract: A Case Study].
    Higashioka K; Miyake N; Nishida R; Chong Y; Shimoda S; Shimono N
    Kansenshogaku Zasshi; 2015 Jul; 89(4):481-4. PubMed ID: 26554225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does isoniazid reduce side effects of intravesical bacillus Calmette-Guerin therapy in superficial bladder cancer? Interim results of European Organization for Research and Treatment of Cancer Protocol 30911.
    Vegt PD; van der Meijden AP; Sylvester R; Brausi M; Höltl W; de Balincourt C
    J Urol; 1997 Apr; 157(4):1246-9. PubMed ID: 9120912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.